Fibroblast growth factor 21 exerts a protective effect on diabetes-induced cognitive decline by remodeling cerebral glucose and neurotransmitter metabolism in mice
Cerebral Cortex · 2024
DOI: 10.1093/cercor/bhad502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebral Cortex, 2024. Verfasst von Xi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Cognitive Dysfunction, Fibroblast Growth Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) causes damage to the central nervous system, resulting in cognitive impairment. Fibroblast growth factor 21 (FGF21) exhibits the potential to alleviate neurodegeneration. However, the therapeutic effect of intracerebroventricular (i.c.v) FGF21 infusion on diabetes-induced cognitive decline (DICD) and its potential mechanisms remain unclear. In this study, the impact of FGF21 on DICD was explored, and 1H nuclear magnetic resonance (NMR)-based metabolomics plus 13C NMR spectroscopy in combine with intravenous [1-13C]-glucose infusion were used to investigate the underlying metabolic mechanism. Results revealed that i.c.v FGF21 infusion effectively improved learning and memory performance of DICD mice; neuron loss and apoptosis in hippocampus and cortex were significantly blocked, suggesting a potential neuroprotective role of FGF21 in DICD. Metabolomics results revealed that FGF21 modulated DICD metabolic alterations related to glucose and neurotransmitter metabolism, which are characterized by distinct recovered enrichment of [3-13C]-lactate, [3-13C]-aspartate, [4-13C]-glutamine, [3-13C]-glutamine, [4-13C]-glutamate, and [4-13C]- γ-aminobutyric acid (GABA) from [1-13C]-glucose. Moreover, diabetes-induced neuron injury and metabolic dysfunctions might be mediated by PI3K/AKT/GSK-3β signaling pathway inactivation in the hippocampus and cortex, which were activated by i.c.v injection of FGF21. These findings indicate that i.c.v FGF21 infusion exerts its neuroprotective effect on DICD by remodeling cerebral glucose and neurotransmitter metabolism by activating the PI3K/AKT/GSK-3β signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
- Key Laboratory of Efficacy Evaluation of Traditional Chinese Medicine and Encephalopathy Research of Zhejiang Province, Wenzhou Medical University, Wenzhou 325035, China.
- Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Wenzhou Medical University, Wenzhou 325035, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Zheng, H., Ni, Z., Shen, Y., Wang, D., Li, W., Zhao, L., Li, C., & Gao, H. (2024). Fibroblast growth factor 21 exerts a protective effect on diabetes-induced cognitive decline by remodeling cerebral glucose and neurotransmitter metabolism in mice. Cerebral Cortex. https://doi.org/10.1093/cercor/bhad502
Vancouver
Zhang X, Zheng H, Ni Z, Shen Y, Wang D, Li W, et al. Fibroblast growth factor 21 exerts a protective effect on diabetes-induced cognitive decline by remodeling cerebral glucose and neurotransmitter metabolism in mice. Cerebral Cortex. 2024. doi:10.1093/cercor/bhad502
BibTeX
@article{Zhang2024,
author = {Zhang, Xi and Zheng, Hong and Ni, Zhitao and Shen, Yuyin and Wang, Die and Li, Wenqing and Zhao, Liangcai and Li, Chen and Gao, Hongchang},
title = {Fibroblast growth factor 21 exerts a protective effect on diabetes-induced cognitive decline by remodeling cerebral glucose and neurotransmitter metabolism in mice},
journal = {Cerebral Cortex},
year = {2024},
doi = {10.1093/cercor/bhad502}
}
EUVIMED